Cargando…
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis
Objective To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens. Design Systematic review and network meta-analysis. Data sources Cochrane Library, PubMed, and Emb...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541168/ https://www.ncbi.nlm.nih.gov/pubmed/26290044 http://dx.doi.org/10.1136/bmj.h4052 |
_version_ | 1782386340823826432 |
---|---|
author | Li, Bao-Zhu Threapleton, Diane Erin Wang, Ji-Yao Xu, Jian-Ming Yuan, Jin-Qiu Zhang, Chao Li, Peng Ye, Qian-Ling Guo, Biao Mao, Chen Ye, Dong-Qing |
author_facet | Li, Bao-Zhu Threapleton, Diane Erin Wang, Ji-Yao Xu, Jian-Ming Yuan, Jin-Qiu Zhang, Chao Li, Peng Ye, Qian-Ling Guo, Biao Mao, Chen Ye, Dong-Qing |
author_sort | Li, Bao-Zhu |
collection | PubMed |
description | Objective To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens. Design Systematic review and network meta-analysis. Data sources Cochrane Library, PubMed, and Embase without language or date restrictions. Study selection Full text reports of randomised controlled trials that compared different eradication treatments for H pylori among adults. Results Of the 15 565 studies identified, 143 were eligible and included. Data on 14 kinds of treatments were available. Of 91 possible comparisons for the efficacy outcome, 34 were compared directly and the following treatments performed better: seven days of concomitant treatment (proton pump inhibitor and three kinds of antibiotics administered together), 10 or 14 days of concomitant treatment, 10 or 14 days of probiotic supplemented triple treatment (standard triple treatment which is probiotic supplemented), 10 or 14 days of levofloxacin based triple treatment (proton pump inhibitor, levofloxacin, and antibiotic administered together), 14 days of hybrid treatment (proton pump inhibitor and amoxicillin used for seven days, followed by a proton pump inhibitor, amoxicillin, clarithromycin, and 5-nitroimidazole for another seven days), and 10 or 14 days of sequential treatment (five or seven days of a proton pump inhibitor plus amoxicillin, followed by five or seven additional days of a proton pump inhibitor plus clarithromycin and 5-nitroimidazole or amoxicillin). In terms of tolerance, all treatments were considered tolerable, but seven days of probiotic supplemented triple treatment and seven days of levofloxacin based triple treatment ranked best in terms of the proportion of adverse events reported. Conclusion Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori. |
format | Online Article Text |
id | pubmed-4541168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-45411682015-08-28 Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis Li, Bao-Zhu Threapleton, Diane Erin Wang, Ji-Yao Xu, Jian-Ming Yuan, Jin-Qiu Zhang, Chao Li, Peng Ye, Qian-Ling Guo, Biao Mao, Chen Ye, Dong-Qing BMJ Research Objective To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens. Design Systematic review and network meta-analysis. Data sources Cochrane Library, PubMed, and Embase without language or date restrictions. Study selection Full text reports of randomised controlled trials that compared different eradication treatments for H pylori among adults. Results Of the 15 565 studies identified, 143 were eligible and included. Data on 14 kinds of treatments were available. Of 91 possible comparisons for the efficacy outcome, 34 were compared directly and the following treatments performed better: seven days of concomitant treatment (proton pump inhibitor and three kinds of antibiotics administered together), 10 or 14 days of concomitant treatment, 10 or 14 days of probiotic supplemented triple treatment (standard triple treatment which is probiotic supplemented), 10 or 14 days of levofloxacin based triple treatment (proton pump inhibitor, levofloxacin, and antibiotic administered together), 14 days of hybrid treatment (proton pump inhibitor and amoxicillin used for seven days, followed by a proton pump inhibitor, amoxicillin, clarithromycin, and 5-nitroimidazole for another seven days), and 10 or 14 days of sequential treatment (five or seven days of a proton pump inhibitor plus amoxicillin, followed by five or seven additional days of a proton pump inhibitor plus clarithromycin and 5-nitroimidazole or amoxicillin). In terms of tolerance, all treatments were considered tolerable, but seven days of probiotic supplemented triple treatment and seven days of levofloxacin based triple treatment ranked best in terms of the proportion of adverse events reported. Conclusion Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori. BMJ Publishing Group Ltd. 2015-08-19 /pmc/articles/PMC4541168/ /pubmed/26290044 http://dx.doi.org/10.1136/bmj.h4052 Text en © Li et al 2015 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Research Li, Bao-Zhu Threapleton, Diane Erin Wang, Ji-Yao Xu, Jian-Ming Yuan, Jin-Qiu Zhang, Chao Li, Peng Ye, Qian-Ling Guo, Biao Mao, Chen Ye, Dong-Qing Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis |
title | Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis |
title_full | Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis |
title_fullStr | Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis |
title_full_unstemmed | Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis |
title_short | Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis |
title_sort | comparative effectiveness and tolerance of treatments for helicobacter pylori: systematic review and network meta-analysis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541168/ https://www.ncbi.nlm.nih.gov/pubmed/26290044 http://dx.doi.org/10.1136/bmj.h4052 |
work_keys_str_mv | AT libaozhu comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT threapletondianeerin comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT wangjiyao comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT xujianming comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT yuanjinqiu comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT zhangchao comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT lipeng comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT yeqianling comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT guobiao comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT maochen comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis AT yedongqing comparativeeffectivenessandtoleranceoftreatmentsforhelicobacterpylorisystematicreviewandnetworkmetaanalysis |